Oberhaching, Germany

Florian Wolschin

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Hexal Ag. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Florian Wolschin. Retrieved from https://idiyas.com/inventor/florian-wolschin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Florian Wolschin: Innovator in Antibody Biotechnology

Introduction

Florian Wolschin is a notable inventor based in Oberhaching, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibody preparations. His innovative work has led to the filing of a patent that addresses important challenges in the industry.

Latest Patents

Florian Wolschin holds a patent related to antibody preparation. The patent focuses on novel methods for removing glycosylated antibody variants from an antibody preparation. This invention not only enhances the quality of antibody preparations but also contributes to the development of pharmaceutical compositions that utilize these antibodies.

Career Highlights

Florian is currently associated with Hexal AG, a prominent company in the pharmaceutical sector. His role at Hexal AG allows him to apply his expertise in biotechnology and contribute to the advancement of medical treatments. His work is characterized by a commitment to innovation and excellence in the field.

Collaborations

Florian collaborates with talented professionals, including Claudia Torella and Benjamin Hackner. These collaborations foster a creative environment that enhances the development of groundbreaking solutions in biotechnology.

Conclusion

Florian Wolschin's contributions to antibody biotechnology exemplify the impact of innovative thinking in the pharmaceutical industry. His patent and ongoing work at Hexal AG highlight the importance of advancements in this critical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…